Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
Dr Weene is concerned that the subtitle of our paper is "sensational." We believe that the subtitle is simply descriptive of the results; medical treatment does delay or prevent the onset of primary open-angle glaucoma in individuals with ocular hypertension.1 We agree with Dr Weene that these results do not imply that all ocular hypertensive individuals should receive treatment. It is clear that many ocular hypertensive patients are at very low risk for developing primary open-angle glaucoma and are probably not good candidates for such treatment. In Kass et al1 and its companion article, 2 we emphasize that treatment should be considered in moderate- to high-risk ocular hypertensive patients, taking into consideration other factors, such as age, general health, and life expectancy. All clinicians have the responsibility of educating patients so that they and their doctors can make informed decisions.
Kass MA, Gordon MO. Ocular Hypertension Treatment Study Results Could Be Misconstrued—Reply. Arch Ophthalmol. 2003;121(7):1070. doi:10.1001/archopht.121.7.1070-a